Universiti Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur 59100

2 studies enrolling now · 3 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Breast Cancer, Chronic Obstructive Pulmonary Disease

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD — Running, not enrolling